Abnormal serum factors in Guillain-Barré syndrome.
The Guillain-Barré Syndrome (GBS) is generally considered to be a cell-mediated immunopathologic disease of the peripheral nervous system (PNS), although the evidence for this is indirect. Both in vitro and in vivo studies of sera from experimental animals with autoimmune demyelinating neuropathies suggest that serum factors, including antibodies to PNS myelin and/or Schwann cells, may be important in the pathogenesis of some of these disorders. More recently, similar in vitro and in vivo techniques, including the production of demyelination following intraneural injection in the rat have been employed to study sera from patients with GBS. The results of these studies demonstrate the presence of factor(s), as yet not fully characterized, that may be important in mediating demyelination. Moreover, in some patients with chronic or relapsing demyelinative inflammatory neuropathies and monoclonal gammopathy, there is evidence of antimyelin antibodies to PNS myelin. Further studies of serum from patients with acute GBS and these other neuropathies may clarify the role of serum factors in acquired inflammatory diseases of the PNS.
D000818:Animals; D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum / Q000276:immunology; D001323:Autoantibodies; D003167:Complement Activation; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000097:blood; D004285:Dogs; D005699:Galactosylceramides / Q000276:immunology; D006168:Guinea Pigs; D006734:Horse Diseases / Q000097:blood; D006736:Horses; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D009186:Myelin Sheath / Q000276:immunology; D010951:Plasma Exchange; D011129:Polyradiculoneuropathy / Q000097:blood*; D011817:Rabbits; D051381:Rats; D012583:Schwann Cells / Q000276:immunology; D013126:Spinal Nerve Roots / Q000276:immunology
D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum; D001323:Autoantibodies; D005699:Galactosylceramides; D007106:Immune Sera